Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
Honglin Zhou, Cheng Ma, Cheng Wang, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173976-173976
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Macrophage Polarization and Its Role in Liver Disease
Cheng Wang, Cheng Ma, Lihong Gong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 364
NOVEL NANOMATERIALS FOR HEPATOBILIARY DISEASES TREATMENT AND FUTURE PERSPECTIVES
Elchin M. Huseynov
Advances in Biology & Earth Sciences (2024) Vol. 9, Iss. Special Issue, pp. 81-91
Open Access | Times Cited: 53
Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease
Xiaobo Zhang, Jie Zhang, Zubing Zhou, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117828-117828
Closed Access | Times Cited: 22
Mulberry leaf (Morus alba L.): A review of its potential influences in mechanisms of action on metabolic diseases
Ruiyuan Zhang, Zhang Qian, Shun Zhu, et al.
Pharmacological Research (2021) Vol. 175, pp. 106029-106029
Closed Access | Times Cited: 80
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
Xian-min Dai, Jiayi Feng, Yi Chen, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 60
SIRT1/SREBPs-mediated regulation of lipid metabolism
Shan Shen, Mingyang Shen, Lirun Kuang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107037-107037
Open Access | Times Cited: 39
Metabolites of traditional Chinese medicine targeting PI3K/AKT signaling pathway for hypoglycemic effect in type 2 diabetes
Yuhan Feng, Yan‐Fang Ren, Xia Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms
Cheng Wang, Cheng Ma, Lihong Gong, et al.
European Journal of Pharmacology (2021) Vol. 912, pp. 174604-174604
Closed Access | Times Cited: 44
Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials
Shenglei Yang, Mingli Sun, Xinan Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Bavachin protects against diet-induced hepatic steatosis and obesity in mice
Wei Xiang, Lin Li, Qianqian Yuan, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 7, pp. 1416-1428
Open Access | Times Cited: 15
Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis
H. J. Yang, Ying Zou, Jun Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
Rou Tang, Rui Li, He Li, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17016-17046
Closed Access | Times Cited: 29
Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice
Duosheng Luo, Ling Yang, Huiting Pang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 21
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
Xuan He, Yubing Li, Xinyu Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
Yang Hai, Ling Zuo, Meng Wang, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 517-517
Open Access | Times Cited: 11
The efficacy of traditional Chinese medicine sequential therapy in non-alcoholic fatty liver disease
Zhang Li, Ying Qian, Hongdi Wu, et al.
Pakistan Journal of Medical Sciences (2025) Vol. 41, Iss. 2, pp. 512-518
Open Access
The Chinese Herbal TiaoGanXiaoZhi Formula Alleviates the Progression of Metabolic‐Associated Fatty Liver Disease by Regulating the Gut Microbiota
Wenying Qi, Xu Cao, Yue Chen, et al.
Portal hypertension & cirrhosis (2025)
Open Access
Therapeutic Potential and Mechanisms of Puerarin in Liver Disease: A Comprehensive Review of Pharmacological Effects and Drug Delivery Innovations
Lokeshvar Ravikumar, Ramaiyan Velmurugan, J Sam Helinto, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100594-100594
Open Access
Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy
Saumya Khanna, Sachindra Kumar, Priyanka Sharma, et al.
Inflammopharmacology (2025)
Open Access
Schisandra chinensis lignans ameliorate hepatic inflammation and steatosis in methionine choline-deficient diet-fed mice by modulating the gut-liver axis
Li-Shan Yan, Jian-Ying Kang, Chunyu Gu, et al.
Journal of Ethnopharmacology (2025), pp. 119801-119801
Closed Access
Rhizoma Atractylodis Macrocephalae reduces HFD-induced NAFLD in mice through activated AMPK mediated inhibition of fatty acid synthesis
Ke Zheng, Rundong Zhang, Yunchang Xin, et al.
Liver Research (2025)
Open Access
Celastrol Stabilizes Glycolipid Metabolism in Hepatic Steatosis by Binding and Regulating the Peroxisome Proliferator-Activated Receptor γ Signaling Pathway
Mingzhu Luo, Yiting Wang, Yanyan Ma, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 64-64
Open Access | Times Cited: 3
Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome
Jin Rong, Zixuan Zhang, Xiaoyu Peng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4783-4798
Open Access | Times Cited: 3
New light on treatment of cervical cancer: Chinese medicine monomers can be effective for cervical cancer by inhibiting the PI3K/Akt signaling pathway
Fangyuan Liu, Jiayue Xu, Rui Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114084-114084
Open Access | Times Cited: 16
Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway
Baofei Yan, Yun Wang, Wenbo Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 115999-115999
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top